<DOC>
	<DOCNO>NCT00001752</DOCNO>
	<brief_summary>Estrogen therapy associate reduce risk coronary heart disease event observational study postmenopausal woman . Although favorable effect estrogen lipoprotein cholesterol level probably account much benefit , direct vascular effect ( vasomotor , hemostatic , anti-inflammatory ) regulate nitric oxide ( NO ) may also importance . We recently show vasodilator effect estrogen coronary circulation due enhance bioactivity NO release endothelium . Estrogen show stimulate synthesis activity enzyme NO synthase enhance NO synthesis endothelial cell culture . Because L-arginine natural substrate enzyme NO synthase , propose combination L-arginine estrogen might additive vasomotor , hemostatic anti-inflammatory effect hypercholesterolemic postmenopausal woman .</brief_summary>
	<brief_title>Vascular Metabolic Effects Hormone Therapy Combined With L-Arginine Postmenopausal Women</brief_title>
	<detailed_description>Estrogen therapy associate reduce risk coronary heart disease event observational study postmenopausal woman . Although favorable effect estrogen lipoprotein cholesterol level probably account much benefit , direct vascular effect ( vasomotor , hemostatic , anti-inflammatory ) regulate nitric oxide ( NO ) may also importance . We recently show vasodilator effect estrogen coronary circulation due enhance bioactivity NO release endothelium . Estrogen show stimulate synthesis activity enzyme NO synthase enhance NO synthesis endothelial cell culture . Because L-arginine natural substrate enzyme NO synthase , propose combination L-arginine estrogen might additive vasomotor , hemostatic anti-inflammatory effect hypercholesterolemic postmenopausal woman .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>All volunteer subject assess study participation , include cardiovascular physical examination rest electrocardiogram . Fasting blood take SMAC , CBC , thyroid battery , lipid level , estradiol FSH level screen protocol 94H0045 . A urine pregnancy test perform woman uterus cessation menses less 6 month . Aspirin nonsteroidal antiinflammatory drug steroidal drug ( oral , ointment , drops inhalation ) stop 10 day prior start study discontinue throughout study . Thirty hypercholesterolemic ( LDL great 130 mg/dL ) postmenopausal woman take estrogenic hormone , antioxidant vitamin ( A , C , E ) , lipidlowering therapy precede 2 month select take part doubleblind , crossover study . No subject plasma estradiol level great 50 pg/ml FSH le 50 pg/ml . No subject blood pressure great 160/100 mm/Hg ( medication ) . No subject smoke cigarette within 6 month . No pregnant subject . No subject history deep venous thrombosis/pulmonary embolus . No subject important chronic medical condition ( cancer , coronary artery disease , diabetes mellitus , COPD , renal disease ) hypothyroidism subject euthyroid thyroid replacement . No subject refuse follow nitraterestricted diet 3 day prior study .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1999</verification_date>
	<keyword>Adhesion Molecules</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Lipoproteins</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Hormone Therapy</keyword>
	<keyword>Postmenopausal Women</keyword>
</DOC>